NeXtGen Biologics is developing a novel extracellular matrix (ECM) product with a pipeline of new technologies. Leveraging a world-class team with expertise in medical devices and breakthrough tissue technologies, the company will offer surgeons unique platform solutions to better manage a myriad of complex conditions seen in general surgery, trauma, cardiovascular diseases, neurosurgery, orthopedics and ophthalmology.